Orthopedic surgeons' perspectives on the decision-making process for the use of bioprinter cartilage grafts

Web-based survey

Àngels Salvador Verges, Luis Fernandez, Francesc López Seguí, Meltem Yildirim, Bertran Salvador-Mata, Francesc García Cuyàs

Research output: Contribution to journalArticle

Abstract

Background: Traumatic and degenerative lesions in the cartilage are one of the most difficult and frustrating types of injuries for orthopedic surgeons and patients. Future developments in medical science, regenerative medicine, and materials science may allow the repair of human body parts using 3D bioprinting techniques and serve as a basis for new therapies for tissue and organ regeneration. One future possibility is the treatment of joint cartilage defects with in vivo 3D printing from biological/biocompatible materials to produce a suitable cell attachment and proliferation environment in the damaged site and employ the natural recovery potential of the body. This study focuses on the perspectives of orthopedic surgeons regarding the key factors/determinants and perceived clinical value of a new therapeutic option. Objective: This study aimed to determine the knowledge and expectations of orthopedic surgeons regarding the clinical use of bioprinted cartilage. Methods: The survey, conducted anonymously and self-managed, was sent to orthopedic surgeons from the Catalan Society of Orthopedic and Traumatology Surgery. In accordance with the method devised by Eysenbach, the Checklist for Reporting Results of Internet E-Surveys was used to analyze the results. The following factors were taken into consideration: the type and origin of the information received; its relevance; the level of acceptance of new technologies; and how the technology is related to age, years, and place of experience in the field. Results: Of the 86 orthopedic surgeons included, 36 believed the age of the patient was a restriction, 53 believed the size of the lesion should be between 1 and 2 cm to be considered for this type of technology, and 51 believed that the graft should last more than 5 years. Surgeons over 50 years of age (38/86, 44%) gave more importance to clinical evidence as compared to surgeons from the other age groups. Conclusions: The perspective of orthopedic surgeons depends highly on the information they receive and whether it is specialized and consistent, as this will condition their acceptance and implementation of the bioprinted cartilage.

Original languageEnglish
Article numbere14028
JournalJournal of medical Internet research
Volume21
Issue number5
DOIs
Publication statusPublished - 1 May 2019

Fingerprint

Cartilage
Decision Making
Transplants
Technology
Human Body
Bioprinting
Traumatology
Regenerative Medicine
Biocompatible Materials
Cell- and Tissue-Based Therapy
Checklist
Internet
Orthopedics
Orthopedic Surgeons
Surveys and Questionnaires
Regeneration
Age Groups
Joints
Cell Proliferation
Wounds and Injuries

Keywords

  • 3D bioprinting
  • Cartilage
  • Graft
  • Online survey
  • Orthopedic surgeons

ASJC Scopus subject areas

  • Health Informatics

Cite this

Orthopedic surgeons' perspectives on the decision-making process for the use of bioprinter cartilage grafts : Web-based survey. / Verges, Àngels Salvador; Fernandez, Luis; Seguí, Francesc López; Yildirim, Meltem; Salvador-Mata, Bertran; Cuyàs, Francesc García.

In: Journal of medical Internet research, Vol. 21, No. 5, e14028, 01.05.2019.

Research output: Contribution to journalArticle

Verges, Àngels Salvador ; Fernandez, Luis ; Seguí, Francesc López ; Yildirim, Meltem ; Salvador-Mata, Bertran ; Cuyàs, Francesc García. / Orthopedic surgeons' perspectives on the decision-making process for the use of bioprinter cartilage grafts : Web-based survey. In: Journal of medical Internet research. 2019 ; Vol. 21, No. 5.
@article{28b76828c5324066b1726d74bb987021,
title = "Orthopedic surgeons' perspectives on the decision-making process for the use of bioprinter cartilage grafts: Web-based survey",
abstract = "Background: Traumatic and degenerative lesions in the cartilage are one of the most difficult and frustrating types of injuries for orthopedic surgeons and patients. Future developments in medical science, regenerative medicine, and materials science may allow the repair of human body parts using 3D bioprinting techniques and serve as a basis for new therapies for tissue and organ regeneration. One future possibility is the treatment of joint cartilage defects with in vivo 3D printing from biological/biocompatible materials to produce a suitable cell attachment and proliferation environment in the damaged site and employ the natural recovery potential of the body. This study focuses on the perspectives of orthopedic surgeons regarding the key factors/determinants and perceived clinical value of a new therapeutic option. Objective: This study aimed to determine the knowledge and expectations of orthopedic surgeons regarding the clinical use of bioprinted cartilage. Methods: The survey, conducted anonymously and self-managed, was sent to orthopedic surgeons from the Catalan Society of Orthopedic and Traumatology Surgery. In accordance with the method devised by Eysenbach, the Checklist for Reporting Results of Internet E-Surveys was used to analyze the results. The following factors were taken into consideration: the type and origin of the information received; its relevance; the level of acceptance of new technologies; and how the technology is related to age, years, and place of experience in the field. Results: Of the 86 orthopedic surgeons included, 36 believed the age of the patient was a restriction, 53 believed the size of the lesion should be between 1 and 2 cm to be considered for this type of technology, and 51 believed that the graft should last more than 5 years. Surgeons over 50 years of age (38/86, 44{\%}) gave more importance to clinical evidence as compared to surgeons from the other age groups. Conclusions: The perspective of orthopedic surgeons depends highly on the information they receive and whether it is specialized and consistent, as this will condition their acceptance and implementation of the bioprinted cartilage.",
keywords = "3D bioprinting, Cartilage, Graft, Online survey, Orthopedic surgeons",
author = "Verges, {{\`A}ngels Salvador} and Luis Fernandez and Segu{\'i}, {Francesc L{\'o}pez} and Meltem Yildirim and Bertran Salvador-Mata and Cuy{\`a}s, {Francesc Garc{\'i}a}",
year = "2019",
month = "5",
day = "1",
doi = "10.2196/14028",
language = "English",
volume = "21",
journal = "Journal of Medical Internet Research",
issn = "1438-8871",
publisher = "Journal of medical Internet Research",
number = "5",

}

TY - JOUR

T1 - Orthopedic surgeons' perspectives on the decision-making process for the use of bioprinter cartilage grafts

T2 - Web-based survey

AU - Verges, Àngels Salvador

AU - Fernandez, Luis

AU - Seguí, Francesc López

AU - Yildirim, Meltem

AU - Salvador-Mata, Bertran

AU - Cuyàs, Francesc García

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Background: Traumatic and degenerative lesions in the cartilage are one of the most difficult and frustrating types of injuries for orthopedic surgeons and patients. Future developments in medical science, regenerative medicine, and materials science may allow the repair of human body parts using 3D bioprinting techniques and serve as a basis for new therapies for tissue and organ regeneration. One future possibility is the treatment of joint cartilage defects with in vivo 3D printing from biological/biocompatible materials to produce a suitable cell attachment and proliferation environment in the damaged site and employ the natural recovery potential of the body. This study focuses on the perspectives of orthopedic surgeons regarding the key factors/determinants and perceived clinical value of a new therapeutic option. Objective: This study aimed to determine the knowledge and expectations of orthopedic surgeons regarding the clinical use of bioprinted cartilage. Methods: The survey, conducted anonymously and self-managed, was sent to orthopedic surgeons from the Catalan Society of Orthopedic and Traumatology Surgery. In accordance with the method devised by Eysenbach, the Checklist for Reporting Results of Internet E-Surveys was used to analyze the results. The following factors were taken into consideration: the type and origin of the information received; its relevance; the level of acceptance of new technologies; and how the technology is related to age, years, and place of experience in the field. Results: Of the 86 orthopedic surgeons included, 36 believed the age of the patient was a restriction, 53 believed the size of the lesion should be between 1 and 2 cm to be considered for this type of technology, and 51 believed that the graft should last more than 5 years. Surgeons over 50 years of age (38/86, 44%) gave more importance to clinical evidence as compared to surgeons from the other age groups. Conclusions: The perspective of orthopedic surgeons depends highly on the information they receive and whether it is specialized and consistent, as this will condition their acceptance and implementation of the bioprinted cartilage.

AB - Background: Traumatic and degenerative lesions in the cartilage are one of the most difficult and frustrating types of injuries for orthopedic surgeons and patients. Future developments in medical science, regenerative medicine, and materials science may allow the repair of human body parts using 3D bioprinting techniques and serve as a basis for new therapies for tissue and organ regeneration. One future possibility is the treatment of joint cartilage defects with in vivo 3D printing from biological/biocompatible materials to produce a suitable cell attachment and proliferation environment in the damaged site and employ the natural recovery potential of the body. This study focuses on the perspectives of orthopedic surgeons regarding the key factors/determinants and perceived clinical value of a new therapeutic option. Objective: This study aimed to determine the knowledge and expectations of orthopedic surgeons regarding the clinical use of bioprinted cartilage. Methods: The survey, conducted anonymously and self-managed, was sent to orthopedic surgeons from the Catalan Society of Orthopedic and Traumatology Surgery. In accordance with the method devised by Eysenbach, the Checklist for Reporting Results of Internet E-Surveys was used to analyze the results. The following factors were taken into consideration: the type and origin of the information received; its relevance; the level of acceptance of new technologies; and how the technology is related to age, years, and place of experience in the field. Results: Of the 86 orthopedic surgeons included, 36 believed the age of the patient was a restriction, 53 believed the size of the lesion should be between 1 and 2 cm to be considered for this type of technology, and 51 believed that the graft should last more than 5 years. Surgeons over 50 years of age (38/86, 44%) gave more importance to clinical evidence as compared to surgeons from the other age groups. Conclusions: The perspective of orthopedic surgeons depends highly on the information they receive and whether it is specialized and consistent, as this will condition their acceptance and implementation of the bioprinted cartilage.

KW - 3D bioprinting

KW - Cartilage

KW - Graft

KW - Online survey

KW - Orthopedic surgeons

UR - http://www.scopus.com/inward/record.url?scp=85067378841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067378841&partnerID=8YFLogxK

U2 - 10.2196/14028

DO - 10.2196/14028

M3 - Article

VL - 21

JO - Journal of Medical Internet Research

JF - Journal of Medical Internet Research

SN - 1438-8871

IS - 5

M1 - e14028

ER -